Transgenic mice as models of human immunodeficiency virus expression and related cellular effects

References

1. Adams J. M., Cory S. 1991; Transgenic models of tumour development. Science 254:1161–1167
   [Google Scholar]
2. Aguzzi A. 1993; The foamy virus family: molecular biology, epidemiology and neuropathology. Biochimica et Biophysica Acta 1155:1–24
   [Google Scholar]
3. Ahmad N., Venkatesan S. 1988; Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241:1481–1485
   [Google Scholar]
4. Barry P. A., Pratt-Lowe E., Unger R. E., Luciw P. A. 1991; Cellular factors regulate transactivation of human immunodeficiency virus type 1. Journal of Virology 65:1392–1399
   [Google Scholar]
5. Benjouad A., Mabrouk K., Moulard M., Gluckman J. C., Rochat M., Van Rietschoten J., Sabatier J. M. 1993; Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV-1). FEBS Letters 319:119–124
   [Google Scholar]
6. Berns A. 1991; Tumorigenesis in transgenic mice; identification and characterization of synergizing oncogenes. Journal of Cellular Biochemistry 47:130–135
   [Google Scholar]
7. Bonneville M., Ishida I., Mombaerts P., Katsuki M., Verbeek S., Berns A., Tonegawa S. 1989; Blockage of αβ T-cell development by TCR γδ transgenes. Nature; London: 342931–934
   [Google Scholar]
8. Brady H. J. M., Pennington D. J., Miles C. G., Dzierzak E. A. 1993; . CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO Journal 12:4923–4932
   [Google Scholar]
9. Brady H. J. M., Miles C. G., Pennington D. J., Dzierzak E. A. 1994; Specific ablation of HIV-Tat expressing cells by conditionally toxic retroviruses. Proceedings of the National Academy of Sciences U.S.A.: 91365–369
   [Google Scholar]
10. Breen E. C., Rezai A. R., Nakajima K., Beall G. N., Mitsuyasu R. T., Hirano T., Kishimoto T., Martinez-Maza O. 1990; Infection with HIV is associated with elevated IL-6 levels and production. Journal of Immunology 144:480–484
    [Google Scholar]
11. Buonaguoro L., Barillari G., Chang H. K., Bohan C. A., Kao V. , Gallo R. C., Ensoli B. 1992; Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. Journal of Virology 66:7159–7167
    [Google Scholar]
12. Chang D. D., Sharp P. A. 1989; Regulation by HIV Rev depends upon recognition of splice sites. Cell 59:789–795
    [Google Scholar]
13. Cohen E. A., Dehni G., Sodroski J. G., Haseltine W. A. 1990; Human immunodeficiency virus Vpr product is a virion-associated regulatory protein. Journal of Virology 64:3097–3094
    [Google Scholar]
14. Corallini A., Altavilla G., Pozzi L., Bignozzi F., Negrini M., Rimessi P., Gualandi F., Brabanti-Brodano G. 1993; Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Research 53:5569–5575
    [Google Scholar]
15. Corboy J. R., Buzy J. M., Zink M. C., Clements J. E. 1992; Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258:1804–1808
    [Google Scholar]
16. Cullen B. R. 1992; Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiological Reviews 56:375–394
    [Google Scholar]
17. Cupp C., Taylor J. P., Khalili K., Amini S. 1993; Evidence for stimulation of the transforming growth factor β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8:2231–2236
    [Google Scholar]
18. De Ronde A., Klaver B., Keulen W., Smit L., Goudsmit J. 1992; Natural HIV-1 Nef accelerates virus replication in primary human lymphocytes. Virology 188:391–395
    [Google Scholar]
19. Dickie P., Felser J., Eckhaus M., Bryant J., Silver J., Marinos N., Notkins A. L. 1991; HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185:109–119
    [Google Scholar]
20. Dillon N., Grosveld F. 1993; Transcriptional regulation of multigene loci: multilevel control. Trends in Genetics 9:134–137
    [Google Scholar]
21. Dillon P. J., Lenz J., Rosen C. A. 1991; Construction of a replication-competent murine retrovirus vector expressing the human immunodeficiency virus type 1 Tat transactivator protein. Journal of Virology 65:4490–4493
    [Google Scholar]
22. Ensoli B., Barillari G., Salahuddin S. Z., Gallo R. C., Wong-Staal F. 1990; Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature; London: 34584–86
    [Google Scholar]
23. Fields B. N. 1994; AIDS: time to turn to basic science. Nature; London: 36995–96
    [Google Scholar]
24. Fisher A. G., Ensoli B., Ivanoff L., Chamberlain M., Petteway S. , Gallo R. C., Wong-Staal F. 1987; The Sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237:888–893
    [Google Scholar]
25. Flores S. C., Marecki J. C., Harper K. P., Bose S. K., Nelson S. K., McCord J. M. 1993; Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proceedings of the National Academy of Sciences U.S.A.: 907632–7636
    [Google Scholar]
26. Frankel A. D., Pabo C. O. 1988; Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189–1193
    [Google Scholar]
27. Frankhauser C., Izaurralde E., Adachi Y., Winfield P., Laemmli U. K. 1991; Specific complex of human immunodeficiency virus type 1 Rev and nucleolar B23 proteins: dissociation by the Rev response element. Molecular and Cellular Biology 11:2567–2575
    [Google Scholar]
28. Frucht D. M., Lamperth L., Vicenzi E., Belchor J. H., Martin M. A. 1991; Ultraviolet radiation increases HIV-long terminal repeat-directed expression in transgenic mice. AIDS Research and Human Retroviruses 7:729–733
    [Google Scholar]
29. Furth P. A., Westphal H., Hennighausen L. 1990; Expression from the HIV-LTR is stimulated by glucocorticoids and pregnancy. AIDS Research and Human Retroviruses 6:553–560
    [Google Scholar]
30. Garcia J. V., Miller A. D. 1991; Serine phosphorylation- independent downregulation of cell-surface CD4 by Nef. Nature; London: 350508–511
    [Google Scholar]
31. Garcia J. V., Alfano J., Miller A. D. 1993; The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. Journal of Virology 67:1511–1516
    [Google Scholar]
32. Glowa J. R., Parlilio L. V., Brenneman D. E., Gozes I., Fridkin M., Hill J. M. 1992; Learning impairment following intracerebral administration of the HIV envelope protein gpl20 or a VIP antagonist. Brain Research 570:49–53
    [Google Scholar]
33. Greaves D. R., Wilson F. D., Lang G., Kioussis D. 1984; Human CD2 3ʹ-flanking sequences confer high level, T cell-specific, position-independent gene expression in transgenic mice. Cell 56:979–986
    [Google Scholar]
34. Green J., Hinrichs S., Vogel J., Jay G. 1989; Exocrinopathy resembling Sjögren’s syndrome in HTLV-1 tat transgenic mice. Nature; London: 34172–74
    [Google Scholar]
35. Grosveld F., Blom Van Assendelft G., Greaves D., Kollias G. 1987; Position-independent, high level expression of the human β-globin gene in transgenic mice. Cell 51:975–985
    [Google Scholar]
36. Guy B., Kieny M. P., Riviere Y., Lepeuch C., Dott K., Girard M., Montagnier L., Lecocq J. P. 1987; HIV F/3ʹ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature; London: 330266–269
    [Google Scholar]
37. Hammes S. R., Dixon E. P., Malim M. M., Cullen B. R., Greene W. C. 1989; Nef protein of human immunodeficiency virus type 1 : evidence against its role as a transcriptional inhibitor. Proceedings of the National Academy of Sciences U.S.A.: 869549–9553
    [Google Scholar]
38. Hart C. E., Ou C. Y., Galphin J. C., Moore J., Bacheler L. T., Wasmuth J. J., Petteway J. S. R., Schochetman G. 1989; Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science 246:488–491
    [Google Scholar]
39. Helland D. E., Welles J. L., Caputo A., Haseltine W. A. 1991; Transcellular transactivation by the human immunodeficiency virus type 1 Tat protein. Journal of Virology 65:4547–1549
    [Google Scholar]
40. Hogan B., Costantini F., Lacy E. 1986 Manipulating the Mouse Embryo: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
41. Howcroft T. K., Strebel K., Martin M. A., Singer D. S. 1993; Repression of MHC Class 1 gene promoter activity by two- exon Tat of HIV. Science 260:1320–1322
    [Google Scholar]
42. Huber B. E., Richards C. A., Martin J. L., Wirth P. J. 1992; Alterations in tumour angiogenesis associated with stable expression of the HIV Tat gene. Molecular Carcinogenesis 5:293–300
    [Google Scholar]
43. Ishida I., Verbeek S., Bonneville M., Itohara S., Berns A., Tonegawa S. 1990; T-cell receptor gamma delta and gamma transgenic mice suggest a role of a gamma gene silencer in the generation of alpha beta T cells. Proceedings of the National Academy of Sciences U.S.A.: 873067–3071
    [Google Scholar]
44. Iwakura Y., Shioda T., Tosu M., Yoshioa E., Hayashi M., Nagata T., Shibuta H. 1992; The induction of cataracts BY HIV-1 in transgenic mice. AIDS 6:1069–1075
    [Google Scholar]
45. Johnston M.I., Hoth D. F. 1993; Present status and future prospects for HIV therapies. Science 260:1286–1293
    [Google Scholar]
46. Jolicoeur P., Laperriere A., Beaulieu N. 1992; Efficient production of human immunodeficiency virus proteins in transgenic mice. Journal of Virology 66:3904–3908
    [Google Scholar]
47. Kessel M., Balling R., Gruss P. 1990; Variations of cervical vertebrae after expression of a Hox 1.1 transgene in mice. Cell 61:301–308
    [Google Scholar]
48. Kestler H. W., Ringler D. J., Mori K., Panicalli D. L., Shehgal P. K., Daniel M. D., Desrosiers R. C. 1991; Importance of the Nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651–662
    [Google Scholar]
49. Khillan J. S., Deen K. C., Yu S. H., Sweet R. W., Rosenborg M., Westphal H. 1988; Gene transactivation mediated by Tat gene of human immunodeficiency virus in transgenic mice. Nucleic Acids Research 16:1423–1430
    [Google Scholar]
50. Kim C. M., Koihe K., Saito I., Miyamaura T., Jay G. 1991; HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature; London: 351317–320
    [Google Scholar]
51. Kim S., Ikeuchi R., Byrn R., Groopman J., Baltimore D. 1989; Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences U.S.A.: 869544–9548
    [Google Scholar]
52. Kimes A. S., London E. D., Szabo G., Raymon L., Tabakoff B. 1991; Reduction of cerebral glucose utilization by the HIV envelope Glycoprotein gp-120. Experimental Neurology 112:224–228
    [Google Scholar]
53. Klimkait T., Strebel K., Hoggan M. D., Martin M. A., Orenstein J. M. 1990; The human immunodeficiency virus type 1 specific protein Vpu is required for efficient virus maturation and release. Journal of Virology 64:621–624
    [Google Scholar]
54. Kollias G., Grosveld F. 1992; The study of gene regulation in transgenic mice. In Transgenic Animals pp 79–98 Grosveld F., Kollias G. Edited by London: Academic Press;
    [Google Scholar]
55. Kopp J. B., Klotman M. E., Adler S. H., Bruggeman L. A., Dickie P., Marinos N. J., Eckhaus M., Bryant J. L., Notkins A. L., Klotman P. E. 1992; Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency type 1 genes. Proceedings of the National Academy of Sciences U.S.A.: 891577–1581
    [Google Scholar]
56. Kopp J. B., Rooney J. F., Woikenberg C., Dorfman N., Marinas N. J., Bryant J. L., Katz S. I., Notkins A. L., Klotman P. C. 1993; Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. Aids Research and Human Retroviruses 9:267–275
    [Google Scholar]
57. Leonard J. M., Abramczuk J. W., Pezen D. S., Rutledge R., Belcher J. H., Hakim F., Shearer G., Lamperth L., Travis W., Fredrickson T., Notkins D. L., Martin M. A. 1988; Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 242:1665–1670
    [Google Scholar]
58. Letvin N. L., King N. W. 1990; Immunologic and pathologic manifestation of the infection of Rhesus monkeys with simian immunodeficiency virus of macaques. Journal of Acquired Immune Deficiency Syndrome 3:1023–1040
    [Google Scholar]
59. Levy D. N., Fernandes L. S., Williams W. V., Weiner D. B. 1993; Induction of cell differentiation by human immunodeficiency virus 1 Vpr. Cell 72:541–550
    [Google Scholar]
60. Locksley R. M., Heinzel F. P., Shepard H. M., Agosti J., Eessalu T. E., Aggarwal B. B., Harlan J. M. 1987; Tumour necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cells. Journal of Immunology 139:1891–1895
    [Google Scholar]
61. Lores P., Boucher V., Mackay C., Pla M., Vonboehmer H., Jami J., Barre-Sinoussi F., Weill J. C. 1992; Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection. AIDS Research and Human Retroviruses 8:2063–2071
    [Google Scholar]
62. Luciw P. A., Cheng-Mayer C., Levy J. A. 1987; Mutational analysis of the human immunodeficiency virus: the orf-b region down-regulates virus replication. Proceedings of the National Academy of Sciences U.S.A.: 841434–1438
    [Google Scholar]
63. Luria S., Chambers I., Berg P. 1991; Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proceedings of the National Academy of Sciences U.S.A.: 885326–5330
    [Google Scholar]
64. Mccune J., Kaneshima H., Krowka J., Namikawa R., Outzen H. , Rabin L., Shih C. C., Lieberman M., Weissman I. . 1991; The scid-hu mouse: a small animal model for HIV infection and pathogenesis. Annual Review of Immunology 9:399–429
    [Google Scholar]
65. Mariani R., Skowronski J. 1993; CD4 down-regulation by Nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proceedings of the National Academy of Sciences U.S.A.: 905549–5553
    [Google Scholar]
66. Massague J. 1990; The transforming growth factor-β family. Annual Review of Cell Biology 6:597–641
    [Google Scholar]
67. Mehtali M., Munschy M., Ali-Hadji D, Kieny M. P. 1992; A novel transgenic mouse model for the in vivo evaluation of antihuman immunodeficiency virus type 1 drugs. AIDS Research and Human Retroviruses 8:1959–1965
    [Google Scholar]
68. Merrill J. E., Koyanagi Y., Chen I. S. 1989; Interleukin-1 and tumour necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. Journal of Virology 63:4404–4408
    [Google Scholar]
69. Nerenberg M., Hinrichs S., Reynolds R., Knowry G., Jay G. 1987; The tat gene of human T lymphotropic virus type 1 induces mesenchymal tumours in transgenic mice. Science 237:1324–1329
    [Google Scholar]
70. Newstein M., Stanbridge E. J., Casey G., Shank P. R. 1990; Human Chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated transactivation in rodent cells. Journal of Virology 64:4565–4567
    [Google Scholar]
71. Niederman T. M. J., Thielan B. J., Ratner L. 1989; Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proceedings of the National Academy of Sciences U.S.A.: 861128–1132
    [Google Scholar]
72. Niederman T. M. J., Garcia J. V., Hastings W. R., Luria S., Ratner L. 1992; Human immunodeficiency virus type 1 Nef protein inhibits NF-KB induction in human T cells. Journal of Virology 66:6213–6219
    [Google Scholar]
73. Niederman T. M. J., Hastings W. R., Luria S., Bandres J. C., Ratner L. 1993; HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology 194:338–344
    [Google Scholar]
74. Pearson L., Garcia J., Wu F., Modesh N., Nelson J., Gaynor R. 1990; A transdominant Tat mutant that inhibits Tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proceedings of the National Academy of Sciences U.S.A.: 875079–5083
    [Google Scholar]
75. Puri R. K., Aggarwal B. B. 1992; Human immunodeficiency virus type 1 Tat up-regulates interleukin 4 receptors on a human B lymphoblastoid cell line. Cancer Research 52:3787–3790
    [Google Scholar]
76. Robert-Guroff M., Popovic M., Gartner S., Markham P., Gallo R. C., Reitz M. S. 1990; Structure and expression of Tat- Rev-, and Nef-specific transcripts of human immunodeficiency virus type I infected lymphocytes and macrophages. Journal of Virology 64:3391–3398
    [Google Scholar]
77. Rosen C. A. 1991; Regulation of HIV gene expression by RNA- protein interactions. Trends in Genetics 1:9–14
    [Google Scholar]
78. Rosenberg Z. P., Fauci A. S. 1990; Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunology Today 11:176–180
    [Google Scholar]
79. Roy S., Katze M. G., Parkin N. T., Edery I., Hovanessian A. G., Sonenberg H. 1990; Control of the interferon-induced 68- kilodalton protein kinase by the HIV-1 Tat gene product. Science 247:1216–1219
    [Google Scholar]
80. Ruhl M., Himmelspach M., Bahr G. M., Hammerschmid F., Jaksche H., Wolff B., Aschauer H., Farrington G. K., Probst H., Bevec D., Hauber J. 1993; Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. Journal of Cell Biology 6:1309–1320
    [Google Scholar]
81. Sanceau J., Wijoenes J., Revel M., Wietzerbin J. 1991; IL-6 and IL-6 receptor modulation by IFN-gamma and tumour necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. Journal of Immunology 147:2630–2637
    [Google Scholar]
82. Sastry K. J., Reddy R. H. R., Pandita R., Totpal K., Aggarwal B. B. 1990; HIV-1 tat gene induces tumour necrosis factor-β (lymphotoxin) in a human B-lymphoblastoid cell line. Journal of Biological Chemistry 265:20091–20093
    [Google Scholar]
83. Schedl A., Montoliu L., Kelsey G., Schutz G. 1993; A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature; London: 362258–261
    [Google Scholar]
84. Schwartz S., Felber B. K., Fenyo E. M., Pavlakis G. N. 1990; Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. Journal of Virology 64:5448–5456
    [Google Scholar]
85. Schwartz S., Felber B. K., Pavlakis G. N. 1991; Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev- dependent and regulated by splicing. Journal of Virology 65:677–686
    [Google Scholar]
86. Shih C.-C., Stoye J. P., Coffin J. M. 1988; Highly preferred targets for retrovirus integration. Cell 53:531–537
    [Google Scholar]
87. Skowronski J., Parks D., Mariani R. 1993; Altered T cell activation and development in transgenic mice expressing the HIV- 1 nef gene. EM BO Journal 12:703–713
    [Google Scholar]
88. Sodroski J. 1992; The human T-cell leukemia virus (HTLV) transactivator (Tax) protein. Biochimica et Biophysica Acta 1114:14–29
    [Google Scholar]
89. Spencer D. C., Price R. W. A. 1992; Human immunodeficiency virus and the central nervous system. Annual Review of Microbiology 46:655–693
    [Google Scholar]
90. Stein B., Kramer M., Rahmsdorf H. J., Ponta H., Herrlich P. 1991; UV-induced transcription from the human immunodeficiencies virus type 1 (HIV-1) long terminal repeat and UV- induced secretion of an extracellular factor that induces HIV-1 transcription in non-irradiated cells. Journal of Virology 63:4540–4544
    [Google Scholar]
91. Strebel K., Daugherty D., Clouse K., Cohen D., Folks T., Martin M. A. 1987; The HIV ‘A’ (Sor) gene product is essential for virus infectivity. Nature; London: 325728–730
    [Google Scholar]
92. Subramanyam M., Gutueil W. G., Bachovchin W. W., Huber B. T. 1993; Mechanism of HIV-1 tat induced inhibition of antigen- specific T cell responsiveness. Journal of Immunology 150:2544–2553
    [Google Scholar]
93. Sullenger B. A., Gallardo H. F., Ungers G. E., Gilboa E. 1990; Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63:601–608
    [Google Scholar]
94. Taylor J. P., Cupp C., Diaz A., Choudury M., Khalili K., Jimenez S. A., Amini S. 1992; Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proceedings of the National Academy of Sciences U.S.A.: 899617–9621
    [Google Scholar]
95. Terwilliger E., Sodroski J. G., Rosen C. A., Haseltine W. A. 1986; Effects of mutations within the 3ʹorf open reading frame region of human T-cell lymphotropic virus type III (UTLV-III/LAV) on replication and cytopathogenicity. Journal of Virology 60:754–760
    [Google Scholar]
96. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. 1994; Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice. Nature; London: 367188–193
    [Google Scholar]
97. Trono D., Baltimore D. 1990; A human cell factor is essential for HIV-1 Rev action. EMBO Journal 9:4155–4160
    [Google Scholar]
98. Viscidi R. P., Mayur K., Lederman H. M., Frankel A. D. 1989; Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 246:1606–1608
    [Google Scholar]
99. Vogel J., Hinrichs S. H., Reynolds R. K., Luciw P. A., Jay G. 1988; The HIV tat gene induces dermal lesions resembling Kaposi’s sarcoma in transgenic mice. Nature; London: 335606–611
    [Google Scholar]
100. Vogel J., Hinrichs S. H., Napolitano L. A., Ngo L., Jay G. 1991; Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene. Cancer Research 51:6686–6690
     [Google Scholar]
101. Vogel J., Cepsoa M., Tschacher E., Napolitano L. A., Jay G. 1992; UV activation of human immunodeficiency virus gene expression in transgenic mice. Journal of Virology 66:1–5
     [Google Scholar]
102. Von Schwedler U., Song J., Aiken C., Trono D. 1993; Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. Journal of Virology 67:4945–1955
     [Google Scholar]
103. Wahl S. M., Allen J. B., Mccartney F., Morganti-Kossman M. C., Kossman T., Ellingsworth L., Mai K. E. H., Mergenhagen S. E., Orenstein J. M. 1991; Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. Journal of Experimental Medicine 173:981–991
     [Google Scholar]
104. Whiting J., Marshall H., Cook M., Krumlauf R., Rigby P. W. J., Stott D., Allemann R. K. 1991; Multiple spatially specific enhancers are required to reconstruct the pattern of Hox-2.6 gene expression. Genes and Development 5:2046–2054
     [Google Scholar]
105. Willey R. L., Bonifacino J. S., Potts B. J., Martin M. A., Klausner R. D. 1988; Biosynthesis, cleavage and degradation of the human immunodeficiency virus 1 envelope glycoprotein gpl60. Proceedings of the National Academy of Sciences U.S.A.: 859580–9584
     [Google Scholar]
106. Willey R. L., Maldarelli F., Martin M. A., Strebel K. 1992; Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. Journal of Virology 66:7193–7200
     [Google Scholar]